Risk factors and outcomes of conversions in robotic and laparoscopic liver resections: A nationwide analysis
Gabriela Pilz da Cunha(Fondazione Poliambulanza Istituto Ospedaliero), Rutger‐Jan Swijnenburg(Amsterdam University Medical Centers), Paul M. Verheijen(Meander Medisch Centrum), Mohammad Abu Hilal(Fondazione Poliambulanza Istituto Ospedaliero), Marc G. Besselink, Koop Bosscha(Jeroen Bosch Ziekenhuis), Jasper P. Sijberden(HealthNet TPO), Mike S.L. Liem(Medisch Spectrum Twente), J. Sven D. Mieog(Leiden University Medical Center), Mariëlle M.E. Coolsen(Maastricht University Medical Centre), Susan van Dieren(Amsterdam University Medical Centers), Ronald M. van Dam(Maastricht University Medical Centre), Gijs A. Patijn(Isala), Eric J.T. Belt(Albert Schweitzer Ziekenhuis), Wouter K. G. Leclercq(Radboud University Nijmegen), Michael F. Gerhards(Radboud University Nijmegen), Wouter J.M. Derksen(University Medical Center Utrecht), Steven J. Oosterling(Spaarne Ziekenhuis), Michelle R. de Graaff(Dutch Institute for Clinical Auditing), Daan J. Lips(Medisch Spectrum Twente), Paul D. Gobardhan(Amphia Ziekenhuis), Türkan Terkivatan(Erasmus MC), Peter B. van den Boezem(Radboud University Nijmegen), Hans Torrenga(Deventer Ziekenhuis), Arjen M. Rijken(Amphia Ziekenhuis), Jeroen Hagendoorn(Utrecht University), T.C.K. Tran(Erasmus MC), Vincent B. Nieuwenhuijs(Isala), Niels F.M. Kok(The Netherlands Cancer Institute), Maarten Vermaas(IJsselland Ziekenhuis), Marieke T. de Boer(University Medical Center Groningen), Hendrik A. Marsman
Cited by 8
Related Papers
Endoscopic Transgastric vs Surgical Necrosectomy for Infected Necrotizing Pancreatitis
|JAMA|2012|735
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|715
United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
|United European Gastroenterology Journal|2017|698
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
|The Lancet. Gastroenterology & hepatology|2019|597